Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer
Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer
Active, not recruiting · NCT04827953 · Registry updated 2024-12-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2024-12-30 | NCT04827953 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Agenus Inc. | 23 |
| Apices Soluciones S.L. | 14 |
| Nelum Corp | 2 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clínico Universitario de Santiago | Santiago de Compostela | Spain | 8 |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | 11 |
| Hospital Universitario Donostia | Donostia / San Sebastian | Spain | 3 |
| Hospital Universitario Marqués del Valdecilla | Santander | Spain | 1 |
| Hospital Universitario Miguel Servet | Zaragoza | Spain | 7 |
| Hospital Universitario Virgen de la Victoria | Málaga | Spain | 8 |